<DOC>
	<DOCNO>NCT01737320</DOCNO>
	<brief_summary>The investigator plan open label randomize control trial compare short-course antibiotic therapy ( &lt; =7 day ) versus longer treatment ( &gt; 7 day ) . The investigator include hospitalized patient gram-negative bacteremia . The investigator primary objective investigate safety efficacy short-course antibiotic .</brief_summary>
	<brief_title>Duration Antibiotics Treatment Gram-negative Bacilli Bacteremia</brief_title>
	<detailed_description />
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>patient gramnegative aerobic bacillus bacteremia , define growth single gramnegative microorganism one blood culture , associate evidence infection ( hyper hypothermia , localized infection , sepsis septic shock ) . We include patient receive appropriate antibiotic treatment 7 day afebrile / hypothermic last 48 hour . Both community hospital acquire gramnegative bacteremia include , regardless antibiotic susceptibility pattern . We allow inclusion patient receive less 7 day clinically stable discharge hospital consider . We recruit patient discharge , stable least 48 hour randomization . We include follow source bacteremia : 1 . Primary bacteremia / unknown source 2 . Urinary tract 3 . Abdominal 4 . Respiratory tract 5 . Central venous catheter ( CVC ) , catheter remove randomization 6 . Skin soft tissue , include surgical site infection 1 . Gramnegative bacteremia due specific infection detail : 1 . Endocarditis / endovascular infection 2 . Necrotizing fasciitis 3 . Osteomyelitis 4 . Abdominal abscess unresolved abdominal source require surgical intervention ( e.g. , cholecystitis ) 5 . Central nervous system infection 6 . Empyema 7 . CVC relate CVCassociated bloodstream infection catheter retain . We permit inclusion patient retain CVCs source bacteremia CVC . 2 . Polymicrobial growth blood culture involve grampositive anaerobe addition gramnegatives ( define either growth two different specie microorganisms blood culture , growth different specie two separate blood culture within episode ( &lt; 48 h ) clinical microbiological evidence source ) . 3 . Specific pathogens include : 1 . Salmonella spp . 2 . Brucella spp . 4 . Immunosuppression , include : 1 . HIV infection 2 . Hematopoietic stemcell transplantation 3 . Neutropenia day randomization 48 hour prior randomization . Patients neutropenic fever presentation afebrile nonneutropenic 48 hour randomization include . 5 . Clinical instability 48 hour randomization , define mean blood pressure &lt; 60 mmHg despite adequate fluid resuscitation vasopressor support . 6 . Repeated positive blood culture organism separate least 24 hour , regardless antibiotic treatment . Patients repeat isolates first 24 hour include . 7 . Uncontrolled focus infection : e.g . abscess drain sufficiently ; nondrained moderate severe hydronephrosis patient bacteremia urinary source ; deep seat intraabdominal infection drain properly . 8 . Fever &gt; 38.0C measure least twice 48 h prior recruitment ; &gt; 38.5C 48 h ; hypothermia &lt; 35.5C measure 48 h. 9 . Previous enrollment trial 10 . Concurrent participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>gram negative bacteremia</keyword>
	<keyword>Duration antibiotic treatment</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>short-course</keyword>
</DOC>